PARTICIPATING COMPANIES

Companies participating at Biotech Showcase 2021 to date

 
USA

180 Life Sciences Corp

 
USA

1984 Ventures

 
Australia

360Biolabs

 
USA

3E Bioventures

 
China

3SBio Inc

 
USA

3T Biosciences

 
Iceland

3Z

 
United Kingdom

4BIO Capital

 
United Kingdom

4D Pharma Plc

 
France

4P PHARMA

 
USA

5AM Ventures

 
USA

6 Dimensions Capital

 
China

7G Bioventures

 
USA

7wireVentures

 
USA

Aagami Inc

 
Finland

Aalto University

 
USA

Abbreos, Inc.

 
USA

AbbVie Ventures

 
USA

ABC

 
USA

Aberdeen Investment Management

 
USA

ABES Venture Partners

 
South Korea

AbTis Co Ltd

 
South Korea

AbTis co., Ltd.

 
USA

Accelmed Partners

 
Spain

Accure Therapeutics SL

 
USA

Accurus Biosciences

 
USA

Aceras Life Sciences

 
USA

Achelios Therapeutics

 
Belgium

Achilles Therapeutics

 
USA

Aclipse Therapeutics

 
France

Acticor Biotech

 
USA

Actinium Pharmaceuticals Inc

 
USA

Acuris Partners

 
USA

Acuta Capital

 
Australia

AdAlta

 
Australia

AdAlta Ltd

 
USA

Adamas Pharmaceuticals, Inc.

 
USA

Adesis Inc

 
USA

Adjuvance Technologies

 
USA

Adjuvant Partners

 
Canada

adMare BioInnovations

 
USA

AdvaMed

 
Spain

Advanced Marker Discovery SL

 
United Kingdom

Advent Life Sciences LLP

 
USA

AdvocacyWorks

 
USA

Adze Biotechnology Inc

 
USA

Aegle Therapeutics Corp

 
South Korea

AF Investment

 
China

AffaMed Therapeutics (HK) Limited

 
USA

Affinia Therapeutics

 
USA

AffyImmune Therapeutics

 
Japan

Aflac Innovation Partners G.K.

 
USA

AgeneBio

 
USA

Agent Capital

 
USA

Agenus

 
United Kingdom

AggioSergeant

 
Australia

Agilex Biolabs

 
Netherlands

Aglaia Oncology Funds

 
USA

AI Therapeutics

 
USA

AIDIA Collective

 
USA

AIFAM Inc

 
USA

AIG

 
USA

Aim Botech

 
USA

AIM-HI Accelerator Fund

 
France

AIScreenings

 
USA

Aisling Capital LLC

 
USA

AIVITA Biomedical

 
Japan

Ajinomoto Co Inc

 
USA

Akadeum Life Sciences Inc

 
USA

Akron Biotechnology

 
USA

Akros Pharma Inc.

 
USA

Akttyva Therapeutics, Inc.

 
United Kingdom

Albion Capital

 
USA

Albumedix

 
USA

Aleon Pharma International Inc

 
USA

Alexandria Venture Investments

 
USA

Algok Bio, Inc.

 
USA

Alignment Ventures

 
USA

Allele Capital Partners, LLC

 
USA

AllerGenis

 
USA

Alliance for Regenerative Medicine

 
USA

Alliance Global Partners

 
USA

AlloMek Therapeutics LLC

 
USA

Alloplex Biotherapeutics Inc.

 
USA

Alloy Therapeutics

 
USA

Allyx Therapeutics

 
China

Alpha Biopharma, Inc.

 
USA

Alpha Bronze

 
Canada

Alpha Cancer Technologies

 
USA

Alphageneron Pharmaceuticals Inc

 
United Kingdom

AlphaSense

 
USA

AlphaSense, Inc.

 
Spain

Alta Life Sciences

 
USA

Alteogen Inc.

 
USA

Alterity Therapeutics Limited

 
France

ALTEVAX

 
USA

Altimate Health

 
USA

Altimmune

 
USA

Altitude Lab

 
USA

Altitude Life Science Ventures

 
USA

Altium Capital Management LP

 
USA

AltrixBio

 
USA

AltruBio, Inc.

 
Australia

Alyra Biotech Pty Ltd

 
USA

Amaro Therapeutics, Inc.

 
Japan

AMD Therapeutics LLC

 
Canada

Ameretat Investment Ltd

 
China

Amgen

 
USA

Amneal Pharmaceuticals

 
USA

Amolyt Pharma

 
USA

AMPEL BioSolutions

 
Canada

Amplitude Ventures

 
USA

AMRI

 
Sweden

AnaMar AB

 
France

Andera Partners

 
USA

Angel Investor

 
USA

Angel Investor Forum

 
Taiwan

Angel to Venture Accelerator

 
USA

Angex Pharmaceutical Inc

 
United Kingdom

Angle Plc

 
USA

Anima Biotech Inc

 
USA

Anpac Bio

 
Japan

ANRI

 
France

Antabio SAS

 
Canada

Antibe Therapeutics Inc

 
USA

Antiva Biosciences

 
USA

Anzu Partners

 
USA

AOA Inc

 
USA

Apercu Parters

 
USA

Apex Capital

 
Finland

Aplagon Oy

 
Israel

Aposense

 
Italy

APOTHEMS

 
USA

Aqua Partners LLC

 
USA

AQUYRE Biosciences

 
USA

Arboretum Ventures

 
USA

ARCA Biopharma Inc

 
USA

ARCH Venture Partners

 
New Caledonia

Arcinova

 
USA

Arcturus Therapeutics Inc

 
USA

Arcus Ventures

 
Argentina

Ardan Pharma

 
USA

Arena Pharmaceuticals

 
USA

ARENSIA Exploratory Medicine

 
Belgium

Argenx BV

 
USA

Aristar Capital

 
USA

Arix Bioscience

 
United Kingdom

Arix Bioscience Plc

 
USA

Arizona Bioindustry Association

 
USA

Arizona Tech Investors

 
United Kingdom

Arrowfield Capital

 
USA

Artery Therapeutics

 
USA

ARTham Therapeutics

 
USA

Asahi Kasei

 
USA

Asahi Kasei America Inc

 
USA

Ascendia Pharmaceuticals

 
USA

Ascendiant Capital

 
USA

Ascentage Pharma

 
USA

ASDERA LLC

 
Japan

ASKA Pharmaceutical Co Ltd

 
USA

AskGene Pharma Inc

 
France

Asklepios Advisors

 
USA

Asklepios BioPharmaceuticals

 
Canada

Aspect Biosystems

 
Canada

Aspect Biosystems Ltd

 
Sweden

Asperion

 
USA

Aspira Women's Health

 
South Korea

Assetplus

 
USA

Astellas Innovation Management LLC

 
Japan

Astellas Pharma Inc.

 
South Korea

Aston Sci.

 
USA

AstraZeneca

 
USA

Astrocyte Pharmaceuticals

 
USA

Asymchem Inc

 
USA

Asymmetry Ventures

 
Belgium

ATB Therapeutics

 
USA

Atelerix Life Sciences

 
United Kingdom

Atelix Ltd

 
USA

ATEM Capital

 
USA

Athena Bioventures

 
USA

Atheneos Ventures, LLC

 
USA

Athos Therapeutics, Inc.

 
South Korea

Atinum Investment

 
France

Atlanthera

 
USA

Atlas Advisors

 
China

ATLATL Innovation Center

 
USA

Atom Bioscience

 
USA

Atomwise

 
Germany

Atriva Therapeutics GmbH

 
Sweden

Attana AB

 
USA

Attillaps Pharmaceuticals

 
Italy

AurorA Science s.r.l.

 
China

Autobio Group Co Ltd

 
USA

AvatarBio

 
Ireland

Avectas

 
USA

Avenir Growth Capital

 
USA

Avery Therapeutics, Inc.

 
Denmark

Avilex Pharma

 
United Kingdom

Avillion LLP

 
USA

AVM Biotechnology

 
USA

Avrobio

 
USA

AxiaVentures

 
Canada

Axiom Real-Time Metrics

 
Japan

AXION Research Inc

 
USA

AxS Pharma LLC

 
USA

Ayma Therapeutics Inc.

 
USA

AZBio

 
USA

AzurRx BioPharma

 
USA

Bachem Americas Inc

 
USA

Back Bay Life Science Advisors LLC

 
Germany

BAG Health Care GmbH

 
USA

BAJ Accelerator

 
USA

Band of Angels

 
United Kingdom

Bank of America

 
USA

Bar Harbor Investment Partnership

 
United Kingdom

Barrington James

 
USA

Bastion Biologics

 
USA

Baudax Bio

 
USA

Bayer

 
USA

Bayer AG

 
Germany

Bayer AG, Pharmaceuticals

 
USA

Bayer U.S. Pharmaceuticals

 
USA

BayMed Venture Partners

 
USA

Beam Therapeutics

 
USA

Behavioral Health Lead

 
Switzerland

BERNINA BioInvest Ltd

 
USA

Best Day Ever Foundation

 
USA

Bexion

 
Japan

Beyond Next Ventures

 
China

BFC Group

 
Netherlands

BGV

 
USA

Bio 9 Ventures

 
USA

Bio Ideations

 
USA

BioAdvance

 
USA

bioAffinity Technologies Inc

 
Australia

Bioasis Technologies Inc

 
Australia

BioCapital Impact Fund

 
USA

BioCentury Inc

 
USA

Biocoast Capital

 
USA

Biocom

 
China

Biocytogen

 
USA

BioEclipse Therapeutics

 
USA

BioFactura Inc

 
France

Biofilm Control

 
Netherlands

Biogeneration Ventures

 
USA

BioHealth Innovation

 
USA

BioIncept, LLC

 
Sweden

BioInvent International AB

 
USA

Bioinvest

 
South Korea

BioLeaders Corp

 
Israel

BioLineRx

 
USA

BioLinkUp LLC

 
Germany

BioM Biotech Cluster Development GmbH

 
USA

BioMap

 
USA

BioMarker Strategies, LLC

 
Switzerland

BioMed Partners

 
USA

BioMediCan, Inc

 
Switzerland

BioMedPartners AG

 
Israel

Biomica

 
USA

BioNJ Inc

 
United Kingdom

BioPartner UK

 
France

Biophytis

 
USA

BioPub

 
Belgium

Bioqube Ventures

 
USA

BioQuest

 
USA

Bios Partners

 
Australia

BioScience Managers Pty Ltd

 
USA

BioSense Global LLC

 
China

Biosion Inc.

 
USA

BioSpace

 
Canada

BIOTECanada

 
USA

Biotech Investment Group

 
Netherlands Ant

Biotech Mountains BV

 
Switzerland

Biotechgate

 
USA

Biotechnology Innovation

 
USA

Biotechnology Investments

 
Singapore

Bioveda Capital Singapore Pte Ltd

 
USA

Bioverge, Inc.

 
Switzerland

BioVersys AG

 
USA

BioWorld

 
USA

BioWorld MedTech

 
USA

BL/SH Financial

 
USA

Blackstone Life Sciences

 
USA

Blinktbi

 
USA

bluebirdbio

 
South Korea

Bluepoint Partners

 
USA

BMGI Group

 
China

BOHE Angel Fund

 
South Korea

Boryung Holdings

 
South Korea

Boryung Pharmaceutical Co Ltd

 
USA

Boston Financial

 
France

Bpifrance Investissement

 
USA

Brace Pharma Capital

 
Japan

Brain Innovation Co Inc

 
Japan

Braizon Therapeutics, Inc.

 
Australia

Brandon Capital Partners

 
USA

Brandy Alfred, Angel Investor

 
USA

Breakout Ventures

 
United Kingdom

Bridge Valley Ventures

 
USA

Bridge Your iCCO Company

 
USA

BridgeBio

 
USA

BriOri BioTech, LLC

 
USA

British Consulate General San Franc

 
USA

Broadview Ventures

 
USA

Brock Capital

 
United Kingdom

Brookstreet Equity Partners LLP

 
France

BROTHERS & PARTNERS Europe

 
Israel

B-Side Pharma

 
USA

BTIG

 
USA

Business France

 
USA

Business Insider

 
USA

Button Capital

 
USA

BVCF

 
USA

C14 Consulting Group LLC

 
USA

C3 Research Associates

 
USA

CaaS Capital Management

 
USA

Cala Health

 
USA

Caladrius Biosciences Inc

 
USA

California Life Sciences Association

 
USA

California Life Sciences Institute

 
USA

Camargo

 
USA

Canaan

 
USA

Cancer Research

 
Israel

Can-Fite BioPharma

 
Switzerland

Canica

 
USA

Canopy Group

 
Canada

Cardiol Therapeutics Inc.

 
Germany

Carela Holding

 
USA

Caribou Biosciences, Inc

 
Australia

Carina Biotech

 
USA

CaroGen Corporation

 
France

CarThera

 
USA

Cassava Sciences

 
USA

Cassel Salpeter & Co

 
USA

Catalent

 
USA

Catalytic Impact Foundation

 
USA

Catalytic Life Sciences

 
Canada

CATO SMS

 
China

CBC Group

 
USA

CBT Advisors

 
USA

Celestial Therapeutics Inc.

 
USA

Cellectar Biosciences Inc

 
USA

Cellino Biotech, Inc.

 
Portugal

CellmAbs Biopharmaceuticals

 
USA

Cello Health BioConsulting

 
USA

Celmatix

 
USA

Cend Therapeutics Inc

 
United Kingdom

Centerview Partners

 
Switzerland

Cerbios-Pharma SA

 
USA

Cerecor Inc

 
Sweden

Cereno Scientific

 
USA

CereVu Medical, Inc.

 
USA

Certara

 
USA

Chameleon Biosciences

 
USA

Chameleon Communications

 
USA

Chaperone Investment

 
USA

Chardan

 
USA

Charles River

 
USA

Charles River Labs

 
Switzerland

Check Orphan

 
USA

CheckOrphan

 
USA

Chemical & Engineering News

 
Germany

Chemovator GmbH

 
China

Chengdu Anticancer Bioscience

 
USA

Chimerocyte Inc

 
USA

ChinaBio Group

 
France

Cilcare

 
USA

Cincinnati Children's Hospital

 
USA

CincyTech

 
USA

Cingulate Therapeutics

 
USA

Cipla

 
Hong Kong

Cisema

 
USA

Citius Pharmaceuticals Inc

 
USA

Citrine Medicine

 
USA

Civilization Ventures

 
USA

Clarametyx Biosciences, Inc.

 
USA

Claremont Creek Ventures

 
United Kingdom

Claris Ventures

 
Canada

Clarivate

 
United Kingdom

Clarivate Analytics

 
USA

Class Bravo Ventures

 
USA

Clayton Biotechnologies, Inc.

 
USA

ClearLight Biotechnologies

 
USA

Clinical Innovation Partners LLC

 
Singapore

Clinical Research Ventures

 
USA

Close Concerns

 
United Kingdom

Closed Loop Medicine Ltd

 
USA

Cmxtwenty

 
USA

CND Life Sciences

 
Singapore

Cocoon Capital Management

 
USA

Code Biotherapeutics

 
USA

Codon Capital

 
USA

Cogentis Therapeutics

 
United Kingdom

Cognetivity Neurosciences

 
United Kingdom

Cognis Pharmalicensing

 
USA

Cognition Therapeutics

 
USA

Cognoa, Inc.

 
USA

Cognoptix

 
USA

Community Bio, Inc.

 
USA

Conamax

 
Germany

Concha Invest GmbH

 
USA

Cone Health Ventures

 
USA

Connecticut Innovations

 
USA

Consulate General of Canada in SF

 
USA

Consulate of Canada

 
Switzerland

Convergence Partners

 
USA

Cordance Medical Inc

 
South Korea

Corestem IND

 
USA

Corsair Pharma Inc

 
USA

Cortado Ventures Fund

 
USA

CoSec Corporate Services

 
USA

Cota Capital

 
United Kingdom

Coulter Partners

 
USA

Covance

 
USA

Cowin Venture

 
USA

CPC Scientific

 
USA

Craig-Hallum Capital Group LLC

 
USA

Creatv MicroTech, Inc.

 
USA

Creo Ingredients

 
United Kingdom

Crescendo Biologics Ltd.

 
USA

Cresco Advisors

 
Netherlands

Cristal Therapeutics

 
France

Crossject

 
USA

Crosswave Management

 
USA

CRV

 
USA

Cryoport

 
South Korea

CrystalGenomics, Inc.

 
USA

CT Innovations

 
USA

CTI Clinical Trial and Consulting Services

 
Canada

CTI Life Sciences Fund

 
USA

Cultivation Capital

 
Japan

Cuorips Inc.

 
USA

Cura Therapeutics

 
France

Curadigm

 
USA

Cure for Kendall

 
USA

Cure Rare Disease

 
USA

CureDuchenne

 
USA

Cures Within Reach

 
Canada

CureSPG50

 
USA

Curi Bio

 
USA

Cyclacel Pharmaceuticals, Inc.

 
USA

Cyclo Therapeutics, Inc.

 
USA

Cytocom, Inc.

 
USA

Cytonus Therapeutics Inc.

 
Japan

CytoPathfinder Inc

 
Sweden

Cyxone AB

 
USA

D TectnologyDx, Inc

 
France

Da Volterra

 
USA

Dabar Investment Associates

 
South Korea

Daewoong Pharmaceutical Co Ltd

 
South Korea

Daewoong Pharmaceutical Ltd.

 
USA

Danaher Innovation Center

 
USA

Darlington Group LLC

 
USA

David Fox Syndicate

 
USA

DaVita Venture Group

 
USA

Daybreak Holdings, LLC

 
South Korea

DAYLI Partners

 
USA

Daylight Capital LLC

 
Switzerland

DB

 
Switzerland

Debiopharm Innovation Fund SA

 
China

Decheng Capital

 
USA

DeckTherapeutics Inc.

 
USA

Deerfield Foundation

 
USA

Deerfield Management

 
USA

DEFTA Partners

 
France

DEFYMED

 
USA

Deka Biosciences, Inc

 
China

Delian Capital

 
USA

DelNova Inc.

 
Hong Kong

Delos Capital

 
USA

Delta TpX

 
USA

DELTA TPX INC.

 
USA

Demy-Colton

 
United Kingdom

Destiny Pharma plc

 
USA

Device of Tomorrow Capital LLC

 
USA

DFB Pharmaceuticals LLC

 
USA

DHVC

 
France

DIACCURATE

 
USA

Diffusion Pharmaceuticals Inc.

 
France

Digitsole SAS

 
USA

DigiTx Partners

 
USA

Dipharma Inc

 
USA

DiscernDx

 
USA

Discerning Light Inc

 
Amer.Virgin Is.

Discover Fund Management, LLLP

 
China

DM Intelligence Ltd

 
USA

Domain Associates LLC

 
France

Domain Therapeutics

 
South Korea

Dong-A ST

 
USA

Dorset Capital LLC

 
Canada

DRI Capital Inc.

 
Belgium

Droia NV

 
USA

DSpakeviciusRD LLC

 
USA

DTx Pharma

 
USA

Dyadic International Inc

 
Japan

DyDo Pharma Inc.

 
USA

Dynamk Capital

 
USA

Dynomics Inc.

 
Japan

EA Pharma Co Ltd

 
Switzerland

Earlybird

 
USA

Easton Capital Investment Group

 
Malaysia

Eaton Square

 
USA

EBD Group

 
Switzerland

Eclosion Ventures

 
Singapore

EDBI Pte Ltd

 
United Kingdom

Edinburgh Molecular Imaging

 
United Kingdom

Edison Group

 
Japan

EditForce Inc

 
Puerto Rico

EGB Ventures

 
Israel

Eight Bridges

 
Japan

Eight Roads Ventures Japan

 
Denmark

Eir Ventures

 
Japan

Eisai Co Ltd

 
USA

Elevian

 
Japan

Elix, Inc.

 
USA

Elixirgen Scientific Inc

 
Luxembourg

Elm Development

 
USA

Elm Street Ventures

 
USA

Elpis Biopharmaceuticals

 
China

Elpiscience Biopharma Ltd

 
USA

EMD Serono

 
USA

Emedgene

 
USA

Emendo Biotherapeutics

 
USA

Emergent BioSolutions

 
Sweden

Emerging Health Ventures

 
France

EMOSIS

 
USA

Empirico

 
USA

Enalare Therapeutics Inc

 
Lithuania

ENERGENAS LLC

 
USA

Engine Room

 
USA

Enteris BioPharma

 
United Kingdom

Enterprise Therapeutics

 
USA

Enveda Therapeutics, Inc.

 
USA

Enzychem Lifesciences

 
USA

Enzyvant

 
USA

Epibone

 
USA

Epidarex Capital

 
Japan

e-Projection K.K.

 
United Kingdom

Epsilogen Ltd

 
USA

Erytech Pharma

 
USA

ESC Advisors

 
Singapore

Esco Ventures X (EVX Ventures)

 
United Kingdom

ESM Biotech

 
Germany

Ethris GmbH

 
France

Eukarys

 
Canada

Eurofins CDMO

 
South Korea

Eutilex

 
USA

Everest Medicines/C-Bridge Capital

 
USA

Evolugate LLC

 
USA

Evolution Life Science Partners

 
USA

Evotec

 
Singapore

EVX Ventures

 
USA

EXXclaim Capital

 
France

EYEVENSYS

 
USA

FA Corporation

 
Germany

faCellitate, Chemovator GmbH

 
Japan

Fast Track Initiative Inc

 
Hungary

FastVentures

 
USA

Fate Therapeutics Inc

 
USA

FDA

 
Canada

Feldan Therapeutics

 
USA

Ferghana Partners Inc

 
Germany

FGK Clinical Research GmbH

 
Canada

Field Trip Health

 
Italy

Finceramica Faenza S.p.a.

 
France

FineHeart

 
USA

Finney Capital

 
USA

First Manhattan Co

 
United Kingdom

Five Corners Capital

 
USA

Flame Biosciences

 
USA

FMG Ventures

 
USA

Foley Hoag LLP

 
Canada

Fonds de Solidarite FTQ

 
Netherlands

Forbion

 
USA

Forkhead BioTherapeutics Inc

 
USA

Fortunatus Capital

 
Switzerland

Forty51 Ventures

 
USA

FOS Capital Partners, LLC

 
Switzerland

Fosun Pharmaceutical AG

 
China

FosunKite

 
USA

Foundation BioVentures

 
USA

Foundation for Angelman Syndrome

 
USA

Foundation for Sarcoidosis Research

 
Ireland

Fountain Healthcare Partners

 
USA

FoxHill Asset Management

 
USA

Frontcourt Ventures

 
Canada

FSD Pharma

 
United Kingdom

F-Star

 
USA

FUJIFILM Diosynth Biotechnologies USA

 
Belgium

Fund Plus

 
Belgium

Fund+ NV

 
Israel

FutuRx

 
USA

Galileo Biosystems Inc

 
China

GBI

 
South Korea

GC Pharma

 
USA

GCF Family Office

 
USA

Geistlich Pharma

 
USA

Gemseki Inc

 
South Korea

GemVax & KAEL Co Ltd

 
USA

GeneLancet Biosciences, Inc

 
USA

GeneOnline US, Inc.

 
USA

Generian Pharmaceuticals Inc

 
Canada

Genesys Capital

 
USA

Genialis, Inc

 
Canada

Genome BC

 
USA

Genomenon, Inc.

 
China

Genor BioPharma Co Ltd

 
France

Genoscience Pharma

 
USA

Genosco

 
USA

GenScript

 
USA

GenScript USA Inc

 
France

GenSight Biologics

 
Singapore

Gero

 
Netherlands

Gilde Healthcare Partners

 
Germany

Gimv

 
Belgium

Gimv NV

 
Israel

GliXogen Therapeutics Ltd.

 
USA

Global Alpha Ventures

 
USA

Global Genes

 
USA

Global Genes.org

 
USA

Global Health Funds

 
USA

Global Health Impact Fund

 
USA

Global Liver Institute

 
USA

GlobalData

 
USA

GlobalData Healthcare

 
United Kingdom

GloblaData Plc

 
USA

Glucosia, Inc

 
Switzerland

GlycoEra

 
Netherlands

Glycostem Therapeutics B.V.

 
Japan

GN Corporation Co Ltd

 
USA

Goldilocks Therapeutics, Inc.

 
United Kingdom

Goldman Sachs

 
USA

Good Health Capital NY

 
Israel

Gordian Surgical Ltd.

 
USA

Gore Range Capital

 
USA

GPG Ventures

 
Thailand

Grand Pacific CRO

 
USA

Graphite Bio

 
USA

Gray Strategic Advisors, LLC

 
Canada

GraySpace Therapeutics Inc.

 
USA

Great Point Partners Llc

 
South Korea

Green Cross Corp

 
USA

Green Park & Golf Ventures

 
USA

GreenField Chemical, Inc.

 
USA

GreenFire Bio

 
Canada

GreenSky Capital

 
USA

Greenwich LifeSciences

 
United Kingdom

GSK

 
USA

GSR Ventures

 
USA

GTAI

 
China

GTJA Investment Group

 
USA

Guangzhou Doublle Bio-products, Inc

 
USA

Gypsy Basin Genomics, Inc.

 
Denmark

H. Lundbeck A/S

 
USA

Habit Design

 
Norway

Hadean Ventures

 
Norway

Hadean Ventures AS

 
France

HalioDx

 
USA

Hanhai International Group

 
South Korea

Hanmi Pharmaceutical

 
USA

Hansoh Bio

 
USA

Happify Health

 
USA

Harbor Street Ventures

 
USA

Harmonix Fund

 
USA

Harvard Business School

 
USA

Hatch Biofund Management LLC

 
USA

Hayan Health Networks

 
Puerto Rico

HAYIM Group

 
USA

HC Wainwright and Co

 
USA

HDT Bio Corp

 
Japan

HEALIOS K.K.

 
USA

Health Equity Capital

 
India

Health Passion Fund

 
USA

Health Tech Capital

 
USA

Healthcare Angels

 
USA

Healthline

 
USA

HealthTech Capital

 
Japan

Heartseed Inc.

 
USA

Heat Biologics

 
USA

HEDA Ventures

 
USA

Helicase Venture

 
Monaco

Helsinn

 
Monaco

Helsinn Investment Fund

 
USA

HemaFlo Therapeutics

 
Germany

HepaRegeniX GmbH

 
USA

Hepion Pharmaceuticals

 
USA

Hercules Capital

 
Singapore

Heritas Capital Management

 
Monaco

Hestia Investments Ltd.

 
South Korea

Heuron

 
China

Hexaell Biotech

 
USA

Hexagon Regenerative Medicine Fund

 
USA

HIG Capital

 
China

HitGen Inc.

 
USA

Hogan & Hartson

 
USA

Hogan Lovells

 
USA

Homology Medicines

 
USA

Hongjing Capital

 
Canada

HOP TECH

 
Australia

Horizon 3 Biotech

 
USA

Horizon Technology Finance Corp

 
USA

Horizon Technology Finance Manageme

 
USA

Horizon Technology Finance Mgmt

 
Portugal

Hovione Capital

 
USA

HOYA

 
Germany

HS LifeSciences GmbH

 
Italy

HTH Srl

 
China

Huagai Capital

 
USA

Hudson Square Capital

 
Singapore

Hummingbird Bioscience Pte Ltd

 
USA

IACTA Pharmaceuticals, Inc.

 
USA

Iaso Ventures

 
Japan

iBody Inc

 
USA

ICON Clinical Research

 
USA

IDefine

 
China

IDG Capital Partners

 
USA

Ignite Social Impact

 
Japan

iHeart Japan Corporation

 
USA

IHP Therapeutics, Inc

 
France

IKTOS

 
USA

Illingworth Research Group

 
USA

Illumina Ventures

 
China

I-Mab Biopharma (Shanghai) Co Ltd

 
China

I-Mab Biopharma Co Ltd

 
United Kingdom

Image Analysis Ltd

 
Canada

IMAGIA

 
USA

IMARA Inc.

 
France

Imcheck Therapeutics

 
Netherlands

IME Medical Electrospinning

 
USA

Immetas Therapeutics

 
South Korea

ImmuneMed Inc

 
Sweden

Immunicum

 
USA

ImmunoGenesis Inc.

 
USA

Immunomic Therapeutics Inc

 
USA

Immunophotonics Inc

 
United Kingdom

Immupharma plc

 
South Korea

Imnewrun Biosciences

 
South Korea

ImNewrun Biosciences Inc.

 
France

IMPLICITY

 
United Kingdom

In Vivo - Pharma Intelligence

 
USA

IN8bio Inc

 
USA

INanoBio Inc

 
USA

InCarda Therapeutics Inc

 
Italy

Indaco Venture Partners

 
USA

Inflammatory Response Research, Inc.

 
USA

Informa

 
USA

Informa Connect

 
Morocco

Informa Connect

 
USA

Informa In Vivo

 
USA

Informa Pharma Intelligence

 
United Kingdom

Informa PLC

 
United Kingdom

InHealth Ventures

 
Netherlands

Inkef Capital

 
Singapore

Innokeys Pte Ltd

 
USA

Innovent Biologics, Inc.

 
USA

Innsightful

 
Germany

INOGROUP

 
USA

Inovations Ventures

 
USA

Inovio Pharmaceuticals

 
Denmark

InProTher ApS

 
USA

In-Q-Tel

 
USA

Intellia Therapeutics

 
USA

Intelligencia Inc

 
Switzerland

InterAx Biotech AG

 
USA

Intersystems

 
United Kingdom

Intract Pharma Limited

 
South Korea

Inventage Lab

 
Lithuania

Invest Lithuania

 
Canada

Investing News Network

 
Canada

Investissement Quebec International

 
Amer.Virgin Is.

Ionic Ventures, LLC

 
Switzerland

IPF Partners

 
Australia

IQVIA

 
France

i-Sep

 
Italy

Italian Angels for Growth

 
Canada

IWEUS Capital

 
USA

Ixchel Pharma

 
USA

J McNary Consulting

 
Taiwan

JAFCO

 
USA

Jain Foundation

 
USA

January Therapeutics

 
Japan

Japan External Trade Organization (

 
Australia

JC Advisory Pty Ltd

 
USA

JDRF T1D Fund

 
France

Jeito Capital

 
USA

Jina Ventures Inc

 
USA

Johnson & Johnson GPH

 
USA

Johnson & Johnson Innovation

 
USA

Johnston Family

 
Japan

Jolly Good Inc

 
USA

Joseph Ventures I LLC

 
USA

Joyance Partners

 
USA

JP Morgan

 
USA

JP Morgan Asset Management

 
USA

JP Morgan Chase

 
USA

JPMorgan

 
Japan

JSR Active Innovation Fund LLC

 
Japan

JT Pharma

 
India

Jubilant Biosys

 
India

Jubilant Therapeutics

 
USA

Julz Co LLC

 
USA

Jupiter Orphan Therapeutics

 
USA

Kairos

 
USA

Kairos Bioconsulting LLC

 
USA

Kaiser Permanente Ventures

 
China

Kaitai Capital

 
USA

KaloCyte, Inc

 
South Korea

Kanaph Therapeutics Inc

 
United Kingdom

Karus Therapeutics

 
USA

Katherine Breedis Investments

 
Japan

Kawasaki Institute of Industrial Promotion

 
USA

KdT Ventures, LLC

 
France

Keen Eye Technologies

 
USA

Keiretsu Northwest

 
USA

Kernal Biologics

 
USA

KESA Partners Inc

 
USA

Keystone Bio

 
USA

Kicker Ventures LLC

 
USA

Kineticos Disruptor Fund

 
USA

Kineticos Life Sciences

 
USA

Kinexum

 
USA

Kingsford Capital Management

 
USA

Kira Pharmaceuticals

 
Canada

KisoJi Biotechnology Inc

 
Israel

Kitov Pharmaceuticals

 
USA

Kiyoizumi Advisory LLC

 
USA

KKH Advisors

 
USA

Kolon TissueGene

 
USA

Korea Investment

 
USA

Korea Investment Partners US, Inc

 
USA

Kowa Research Institute Inc

 
United Kingdom

Kreos Capital

 
USA

KSV Global Innovations

 
USA

KTB Ventures

 
United Kingdom

Kuano Ltd

 
France

Kurma Partners

 
USA

Kurome Therapeutics

 
South Korea

Kwangdong Pharmaceutical Co Ltd

 
Japan

Kyowa Kirin

 
Japan

Kyowa Kirin Co Ltd

 
USA

Kyto Technology and Life Science

 
USA

KytoTechnology and Life Science Inc

 
Spain

Laboratorios Rubio SA

 
USA

LabPulse

 
USA

Labpulse.com

 
USA

Lacerta Bio Inc.

 
USA

Lactocore, Inc.

 
USA

Ladenburg Thalmann

 
USA

Ladenburg Thalmann & Co. Inc.

 
USA

Lake Capital

 
USA

LambdaVision

 
USA

Landmark Angels/Family Office

 
Mexico

Lantana BioSoft Fund

 
USA

Latham Biopharm Group

 
China

Laurel Venture Capital Ltd

 
Canada

Laurent Pharmaceuticals

 
China

LAV Management Co Ltd

 
Netherlands

Lead Pharma

 
South Korea

LegoChem Biosciences

 
USA

LEO Innovation Lab Ventures

 
USA

Leukemia & Lymphoma Society Therapy

 
USA

Levine Media Group

 
Canada

Lexaria Bioscience Corp

 
South Korea

LG Chem

 
Netherlands

Liberi Group

 
USA

Life Science Angels

 
USA

Life Science Washington

 
United Kingdom

LifeArc

 
USA

LifeTech Capital Aegis

 
United Kingdom

LIfT BioSciences

 
USA

LightDeck Diagnostics

 
USA

Lightspeed Microscopy

 
USA

Likarda, LLC

 
USA

Lilly

 
China

Lilly Asia Ventures

 
USA

Lincoln Park Capital

 
USA

Lineage Cell Therapeutics

 
Australia

Linear Clinical Research

 
China

Lingmed Limited

 
USA

Little Hercules Foundation

 
USA

Locust Walk

 
USA

LogicBio

 
USA

Loki Therapeutics

 
USA

Loncar Investments

 
USA

Lone Star Bio Ventures

 
Israel

LongeVC

 
USA

Lonza

 
Germany

Lonza AG

 
China

LoyalValley Capital

 
Netherlands

LSP

 
United Kingdom

LSX Ltd

 
USA

Luciole Pharmaceuticals

 
USA

Luminary Therapeutics

 
United Kingdom

Luminous Ventures

 
Canada

Lumira Ventures

 
Taiwan

Lumosa Therapeutics

 
Denmark

Lundbeckfonden Emerge

 
Denmark

Lundbeckfonden Ventures

 
China

Luoxin Biotechnology(Shanghai) Co.,

 
Japan

Luxna Biotech Co Ltd

 
USA

LYFE Capital

 
USA

Lykan BioScience

 
USA

Lymo Ventures-Life Science Angels

 
China

Lynx Capital

 
China

Lynx Capital Limited

 
Japan

M Bio Technology Inc.

 
Netherlands

M Ventures BV

 
France

MAbSilico

 
Switzerland

Mabylon AG

 
United Kingdom

Macrophage Pharma

 
Netherlands

Madam Therapeutics

 
Canada

Magnet Strategy Group Cross-Border

 
USA

MaidStone Life Sciences LLC

 
USA

Mariam Global Health LLLP

 
USA

Marizyme Inc.

 
Japan

Maruho Co Ltd

 
USA

Matica Biotechnology, Inc.

 
USA

Matrix Partners China

 
Japan

MATRIXOME, Inc.

 
USA

MaveriX Oncology Inc

 
USA

McDermott Will & Emery

 
USA

McDermott Will & Emery LLP

 
USA

MD Anderson

 
USA

Medable

 
Germany

Medac GmbH

 
Canada

MedBiome

 
USA

MedCity News

 
USA

MEDIC Life Sciences

 
Japan

Medical Incubator JP K.K.

 
USA

Medicines360

 
Japan

medilabo RFP Inc

 
France

Medincell

 
Canada

Mediphage Bioceuticals, Inc

 
South Korea

Medivate Partners

 
Japan

Medrx

 
USA

Medtech Insight

 
USA

Mekanistic Therapeutics, LLC

 
France

MELLISIM

 
United Kingdom

Meltwind Advisory LLP

 
Switzerland

Memo Therapeutics AG

 
USA

Merck

 
USA

Merck & Co Inc

 
USA

Merck and Co

 
Germany

Merck Heathcare KGaA

 
USA

Merck KGaA

 
USA

Mercodia

 
USA

Mergermarket

 
USA

MergerMarket Acuris Group

 
USA

Mesa Verde Venture Partners

 
USA

Mesoblast

 
USA

Meta Health Ventures

 
USA

Metagenomi

 
Japan

Metcela Inc.

 
USA

Metis Lighthouse

 
USA

Meyers Investments Family Lp

 
USA

MichBio

 
United Kingdom

Microbiotica

 
USA

Microbiotix Inc

 
USA

Micron Biomedical, Inc.

 
USA

Micronoma

 
USA

Mid Atlantic Bio Angels

 
Netherlands

Mike Del Prado Investments

 
USA

Militia Hill Ventures

 
United Kingdom

MiNA Therapeutics

 
Israel

MinInvasive ltd

 
South Korea

Mint Venture Partners

 
USA

Mira Life Science Ventures

 
South Korea

Miraeasset Capital Co Ltd

 
USA

Mission Bio

 
USA

Mission: Cure

 
USA

MIT Alumni Angels of Northern CA

 
Luxembourg

Mitotech S.A.

 
Japan

Mitsubishi Chemical Co

 
USA

Mitsubishi Tanabe Pharma

 
United Kingdom

Mitsubishi Tanabe Pharma Europe Ltd

 
Singapore

Mitsubishi UFJ Trust and Banking Co

 
Japan

Mitsui & Co Global Investment Inc

 
USA

Mitsui Global Investment

 
USA

Mizuho Securities USA LLC

 
Japan

Mochida Pharmaceutical Co Ltd

 
USA

Modality.AI

 
USA

Modality.AI Inc

 
USA

Molex LLC

 
United Kingdom

Momentum Biotech

 
Canada

Monogenic Pharmaceuticals

 
Canada

Montreal International

 
USA

Moore Venture Partners

 
United Kingdom

Morgan Prestwich

 
China

Morningside Ventures

 
USA

MP Healthcare Venture Mgmt Inc

 
USA

MRIGlobal

 
USA

MRL Ventures Fund

 
China

MSA Capital

 
USA

MSQ Ventures

 
Bahamas

Mundo Advisors

 
USA

MVP Capital Partners

 
France

My Cyber Royaume

 
Canada

My Intelligent Machines

 
France

MyBrain Technologies

 
USA

N1 Life

 
USA

Nan Fung Life Science

 
Canada

Nanology Labs Inc.

 
Israel

NanoScent

 
USA

NanoTomer, inc

 
USA

NanoValent Pharmaceuticals, Inc

 
USA

NanoView Biosciences

 
Canada

Nanovista Inc.

 
USA

Nassau Street Ventures

 
USA

National Biodefense Science Board

 
USA

National Institutes of Health

 
USA

Natl Foundation for Cancer Research

 
USA

Nature Publishing Group

 
Japan

NB Health Laboratory Co Ltd

 
USA

NCL Technology Ventures

 
Sweden

NDA Group

 
USA

NEA

 
Utd.Arab Emir.

Negma Group Ltd

 
USA

NeoImmuneTech

 
France

Neomedlight

 
United Kingdom

NeRRe Therapeutics

 
Israel

Neshima Medical

 
USA

Neumentum Inc

 
USA

Neuraptive Therapeutics

 
Switzerland

Neurimmune AG

 
Canada

Neuro Solutions Group

 
USA

Neurocrine Biosciences

 
Israel

Neurogenesis Ltd

 
USA

NeuroHealth Technologies

 
Canada

Neurolign Technologies Inc.

 
USA

NeuroPerspective

 
USA

Neurophth Therapeutics

 
Australia

Neuroscience Trials Australia

 
USA

Neurotech Reports

 
Italy

Neuro-Zone srl

 
USA

New Enterprise Associates

 
United Kingdom

New Grounds Venture Capital

 
USA

New Jersey Bioscience Center The Incubator at North Brunswick

 
USA

New Orleans Business Alliance

 
USA

New Perspectives Inc

 
USA

New Rhein Healthcare Investors

 
USA

Newark Venture Partners Fund, L.P.

 
Italy

Newron Pharmaceuticals SpA

 
Japan

Newton Biocapital

 
Japan

NextGeM Inc

 
USA

NIA/NIA/DEA/OSBR

 
South Korea

NIBEC

 
USA

Nieuw Amsterdam Advisors

 
USA

NIH

 
USA

NIH NCATS

 
United Kingdom

NIHR

 
Japan

Nippon Shinyaku Co Ltd

 
USA

Nirova BioSense, Inc.

 
Japan

Nobelpharma Co Ltd

 
USA

Noble Life Science Partners

 
United Kingdom

Nodenza

 
Switzerland

Nodes Advisors AG

 
USA

NomoCan Pharmaceuticals

 
USA

Nomura Securities Int'l

 
Switzerland

Nora Leonardi Consulting

 
Denmark

Nordea

 
USA

Northlea Partners LLLP

 
USA

Northpond Ventures

 
Netherlands

NORTHSEA THERAPEUTICS BV

 
USA

NorthStar Medical Technologies

 
USA

Northway Biotech Inc

 
USA

Notable Labs

 
Belgium

NOVADIP

 
France

Novadiscovery

 
Germany

Novaliq GmbH

 
USA

Novartis

 
USA

Novatio Ventures

 
USA

Novavax Inc

 
USA

Novian Health

 
USA

Novo Nordisk

 
Denmark

Novo Nordisk A/S

 
USA

Novotech CRO

 
Germany

Noxxon Pharma AG

 
Germany

NOXXON Pharma NV

 
USA

nRichDX Inc.

 
South Korea

NS Investment

 
USA

NSIP LLC

 
Australia

Nucleus Network

 
USA

Nuventra Pharma Sciences

 
United Kingdom

o2h Ventures Ltd

 
Puerto Rico

Oasis Capital, LLC

 
USA

Oberland Capital

 
USA

OBI Pharma, Inc.

 
USA

OCA Ventures

 
USA

OCMS Bio, LLC

 
USA

OCV Partners

 
USA

Ogilvy

 
Japan

Oita University Institute of Advanced Medicine

 
Japan

Oligogen Inc

 
South Korea

OliX Pharmaceuticals

 
United Kingdom

Omideon Limited

 
USA

OMX Ventures

 
France

Oncodesign

 
France

Oncodiag

 
USA

Oncology Impact Partners

 
USA

OncoMyx Therapeutics Inc

 
USA

Onconova Therapeutics Inc

 
USA

Oncoustics

 
Switzerland

One Capital Group

 
Australia

OneVentures

 
USA

ONO Pharma

 
USA

Ono Pharma USA Inc

 
USA

Ontario Trade and Investment Office

 
United Kingdom

Oppilotech Ltd

 
France

OptimHal ProtecSom

 
Canada

OPTT Inc.

 
United Kingdom

Optum Ventures

 
USA

Opus Biotech Communications

 
USA

Orange Grove Bio

 
USA

OrbiMed Advisors

 
USA

OrbiMed Advisors LLC

 
USA

Oresund Capital LLC

 
USA

Origami Therapeutics, Inc.

 
USA

Oriole Therapeutics, Inc.

 
Canada

Orion Biotechnology Canada Ltd.

 
USA

Orlance Inc

 
USA

Orphan Disease Center

 
USA

OS Fund

 
South Korea

Oscotec, Inc.

 
USA

OSF Healthcare Ventures

 
USA

Oshun Medical

 
USA

Osmol Therapeutics, Inc.

 
USA

OssiFi Inc

 
USA

Otsuka Pharmaceutical

 
USA

Our Odyssey

 
Canada

Ovensa Inc.

 
USA

Ovid Therapeutics Inc.

 
United Kingdom

Oxford BioMedica

 
United Kingdom

Oxford BioMedica PLC

 
USA

Oxford Club

 
Belgium

Oxurion NV

 
United Kingdom

Oxyrane

 
USA

Pacylex Pharmaceuticals

 
USA

Paladin Capital Group

 
USA

Palladio Biosciences

 
USA

Palladio Biosciences, Inc.

 
USA

Panacea Venture

 
China

Panacea Venture Healthcare

 
Italy

Panakes Partners

 
Canada

Pangaea Ventures

 
USA

PANO THERAPEUTICS, INC.

 
USA

Pantherics Inc.

 
USA

Pappas Capital

 
South Korea